NL-OMON40254CompletedNot Applicable
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgery - EPICS study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Catharina-ziekenhuis
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •1. Age of 18 years or more undergoing isolated CABG or AVR
- •2. Preoperative Hb < 7 mmol/l.
Exclusion Criteria
- •1. Off pump surgery.
- •2. Combination surgery.
- •3. Re-operation.
- •4. Emergency operation.
- •5. Patients with bleeding disturbances;e.g, hemophilia and patients with chronic liver disease.
- •6. Concomitant use of cyclosporine prior to, during or following surgery
- •7. Female patients who are pregnant or planning to become pregnant.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgeryPatients (male and female) scheduled for coronary artery bypass grafting surgery (CABG) or single Aortic Valve replacement (AVR) on conventional cardiopulmonary bypass.EUCTR2012-002076-14-NL100
Terminated
Phase 4
Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac SurgeryAnemia, Iron-DeficiencyDysfunction Postoperative, Cardiac Surgery HeartNCT02210949Catharina Ziekenhuis Eindhoven7
Recruiting
Phase 2
Effect of erytropoetin and Ferinject on transfusioIron deficiency anemiaIRCT20221021056256N1The Shahid Beheshty University100
Not yet recruiting
Unknown
prophylactic erythropoietiHaematological Disordersanemia in critically ill patientsPACTR201803003169385Asmaa Fawzy Amer100
Recruiting
Phase 3
Evaluating the efficacy of Erythropoietin and Intravenous Iron on transfusion requirements in patients undergoing cardiac surgeryiron deficiency anemia.IRCT20190121042447N1Tehran University of Medical Sciences154